Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Clinical research study
Current Issue
Editorial Board
Literature Review
Narrative review
Original Article
Research Article
Review Article
Short Report
Surgical techniques
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Clinical research study
Current Issue
Editorial Board
Literature Review
Narrative review
Original Article
Research Article
Review Article
Short Report
Surgical techniques
View/Download PDF

Translate this page into:

55 (); 64-68
doi:
10.1016/j.jor.2024.03.034

Future directions for early detection of fracture related infections

Singapore General Hospital Department of Orthopaedic Surgery, Singapore

⁎Corresponding author: Hui Wen Tay. huiwen.tay@mohh.com.sg

Disclaimer:
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Fracture related infection (FRI) refers to pathogens infecting a fracture site and hence impeding fracture healing. It is a significant complication that carries substantial disease burden and socio-economic costs, but has had limited scientific development. Hence, this paper will review the existing strategies for early detection of FRI, in the form of serum markers, molecular diagnostics and imaging modalities, and further discuss potential future directions for improved detection of FRI.

The Anti-infection Global Expert Committee (AIGEC) developed a consensus definition for FRI in 2017, which includes confirmatory and suggestive criteria for diagnosis of FRI. Existing strategies for diagnosis include clinical, laboratory, histopathological, microbiological and radiological investigations.

With increasing recognition of FRI, early detection is crucial for early treatment to be enforced. We have identified potential areas for future development in diagnostics for early detection of FRI, which are discussed in this manuscript. They include inflammatory cytokines, serum calcium levels, platelet count, improved management of histopathological and microbiological specimens, metagenomics, wound biomarkers, gut microbiota analysis, and novel imaging technologies.

1

1 Introduction

Fracture related infection (FRI), whereby pathogens infect the fracture site and impede fracture healing, has been gaining increasing traction and recognition. Incidence of FRI has been reported to be 1–2% in closed fractures, and up to 30 % in open fractures.1 It can potentially result in delayed union or nonunion in over one third of patients, may require repeated operations, prolonged antibiotic treatment, and can result in loss of function or need for amputation.2 While significant advancements and innovations in surgical treatment techniques have enabled rapid fracture fixation and recovery of patients, FRI persists as a significant complication that carries substantial disease burden and socio-economic costs.

FRI is a complex condition that can manifest at a myriad of anatomic locations, with multiple possible fracture patterns, and different degrees of soft tissue injury. Hence, arriving at one definition to encompass this wide variety of clinical scenarios is challenging. It was only in 2017 that an international consensus definition of FRI was agreed upon by the Anti-infection Global Expert Committee (AIGEC).3 Confirmatory criteria include the presence of a fistula or wound breakdown, two positive microbiology results of intra-operative deep tissue cultures, or >5 neutrophils per high powered field on histology. Suggestive criteria include elevated serum inflammatory markers, clinical signs of infection, one positive culture, or positive imaging.

Prior lack of a consensus definition of FRI meant that FRI research had significant heterogeneity amongst the included patient population as different definitions were utilized when conducting prior studies. Hence, most management guidelines had been based on data derived from prosthetic joint infections (PJI). Yet, fracture fixation behaves differently from arthroplasty in terms of stability. Hence, principles for diagnosis and management of PJI cannot be extrapolated directly to FRI. With the current FRI consensus definition, a more concerted effort can be made to study FRI and allow for appropriate evidence-based clinical guidelines for the diagnosis, prevention and management to be developed for FRI. Therefore, we will be reviewing the existing strategies for early detection of FRI, and discuss potential future directions for improved detection of FRI.

2

2 Existing Strategies for Diagnosis of FRI

The first step to reducing the poor outcomes incurred from FRI would be to achieve early and accurate diagnosis. However, it is often challenging to arrive at the diagnosis as clinical manifestations are varied.

2.1

2.1 Clinical

Patients may exhibit clinical manifestations pathognomonic for FRI, such as fistula, sinus tract, wound breakdown, or visible pus from wound at the site of the fracture, which are part of the confirmatory diagnostic criteria established by AIGEC.3 A retrospective cohort study by Sigmund et al. found sinus tract to have a sensitivity of 45.7 % and specificity 100.0 %, and visible pus to have a sensitivity of 50.0 % and specificity of 96.8 %.4 Other clinical signs and symptoms of pain, erythema, swelling, warmth, fever, persistent post-operative drainage from wound, and new joint effusion, are clinical criteria that may suggest the presence of FRI. However, they are often difficult to distinguish from the expected inflammatory responses to the traumatic soft tissue damage from the primary injury or surgical procedure, delayed fracture healing due to other patient factors, and pain from post-traumatic arthrosis. Hence, the presence of suggestive criteria should prompt the clinician to further evaluate for FRI through laboratory and imaging investigations.

2.2

2.2 Serum markers

Elevated serological biomarkers of C-reactive protein (CRP), white blood cell (WBC) count and erythrocyte sedimentation rate (ESR) may suggest FRI. Sigmund et al. evaluated the diagnostic value of CRP, which demonstrated a 67 % sensitivity and 60 % specificity.4 Other inflammatory conditions such as hospital acquired infections, post-fracture and post-surgery inflammatory responses also increase CRP. Hence, relying solely on CRP may lead to overtreatment, which may include unindicated invasive revision surgery and prolonged antibiotic therapy. Furthermore, infection by a low virulence organism or biofilm formation on implant surfaces which shelter pathogens from the host immune response can result in false negative results and hence missed diagnoses.5 Instead, these serum biomarkers may demonstrate more utility in patients who develop late FRI, whereby a meta-analysis found CRP to have a 77.0 % sensitivity and 67.9 % specificity in the detection of late FRI, WBC count with a 51.7 % sensitivity and 67.1 % specificity, and ESR with a 45.1 % sensitivity and 79.3 % specificity.6 CRP may also have a role in prognostication, whereby the mean CRP level of less virulent versus high virulence micro-organisms was significantly lower at 10.04 mg/L in former, as compared to 26.31 mg/L in the latter.4 Arguably, the sensitivities and specificities of these serological markers are still low in early and late FRI. Hence, they should not serve as confirmatory tests, but rather prompt further evaluation when elevated.

2.3

2.3 Histopathology and microbiology

Use of Gram stain for Gram positive or negative bacteria, Ziehl-Neelsen stain for tuberculosis, and Grocott methenamine silver stain for invasive fungal infections, can identify the presence of microorganisms in deep tissues obtained during an operative intervention.

The positive culture of distinct pathogens obtained from at least two separate deep tissue or implant (sonication) specimens is considered a confirmatory criterion of FRI. The identification of the pathogen can aid with prognostication (eg. whether the organism is low or high virulence) and guide appropriate culture-directed antibiotic therapy. To note is that pathogens causing late onset FRI are often skin commensals, and hence interpretation of the results may be confounded by the possibility of contamination if inappropriate sampling protocols are utilized. Furthermore, organisms may be slow growing in a biofilm, and thus result in false negative results.

Sonication of implant parts is the utilisation of sound waves to dislodge biofilm on implant surfaces for culture. A semiquantitative cut off point for the number of colony forming units helps differentiate infection from contamination. A systematic review by Onsea et al. that included five studies on sonication fluid culture concluded that sonication may be a useful adjunct, but that there is no evidence that it is superior to tissue culture.7 Even existing studies of sonication in the context of PJI have found that sonication has a lower sensitivity and specificity than tissue cultures,8 and such results could be extrapolated to the context of FRI.

The original consensus definition of FRI did not include the presence of polymorphonuclear neutrophils (PMNs) visualized under high-power field as part of the confirmatory diagnostic criteria. However, a recent study has demonstrated that for patients with late onset or chronic FRI, the complete absence of PMNs has a high correlation with aseptic nonunion, while >5 PMNs per HPF (at 400x magnification) is always associated with infection,9 and this criterion has now been included as a confirmatory sign of FRI.

2.4

2.4 Imaging

Plain radiographs are often the first line imaging to monitor for fracture healing. Radiological findings of bone lysis, implant loosening, sequestration, non-union and periosteal reaction at non-fracture sites are suggestive of FRI. A study by Li et al. found that radiolucent lines and periosteal reaction were associated with infection, with a low sensitivity (16.4 % and 12.1 % respectively) and high specificity (90.5 % and 94.8 % respectively).10 However, studies have demonstrated that within the first two weeks after fracture fixation, bone does not show signs of osteomyelitis or osteolysis despite having an infected implant.11 Hence, diagnosis of FRI on plain radiographs may lead to delayed diagnosis.

Three-phase bone scan has a limited role in FRI. With a high sensitivity but low specificity,12 it can be utilized as a screening tool in patients with a low pre-test probability of infection, whereby a negative bone scan result likely excludes the presence of FRI.

Computed tomography (CT) scans can provide more bony detail, better demonstrating the presence of poor fracture healing, implant loosening, osteolysis, sequestration, and periosteal reaction. However, the sensitivity and specificity for FRI are poor (47 % and 60 % respectively).13

Magnetic resonance imaging (MRI) is more useful at delineating soft tissue pathology. However, despite utilizing metal artefact reduction sequencing techniques, metal implants would still result in significant scattering, hence obscuring details and making interpretation of scan images challenging. In addition, features of infection, inflammation and post-surgical changes appear similar on MRI, hence resulting in a poor specificity and limited utility for the detection of FRI.

3

3 Future directions for early detection of FRI

There is a paucity of research related to laboratory and imaging diagnostics for FRI, in contrast to the extensive studies that have been performed in PJI. Hence, results and conclusions from studies for PJI are commonly extrapolated to FRI. However, in FRI, numerous possible fracture patterns, different extents of soft tissues injury, varied patient conditions (whether isolated or polytrauma) and the fact that fracture fixation devices can be removed without loss of function once osseous healing is completed (unlike in PJI where implant removal means loss of the function of the joint) are some aspects whereby FRI differs from PJI. As there are key differences in the pathology, unique strategies for evaluating FRI should be investigated in future studies.

3.1

3.1 Serum markers

Besides routinely used inflammatory markers of CRP, WBC count and ESR, other inflammatory cytokines can be studied to evaluate their utility and cut off values that would support the diagnosis of FRI. A literature search on Pubmed on the role of inflammatory cytokines yielded four studies. Interleukin-6 (IL-6) is a pleiotropic cytokine that participates in tissue repair and regeneration. During tissue injury and infection, IL6 is rapidly generated, and high IL-6 levels may suggest underlying FRI. Zhao et al. has found IL-6 to have a similar diagnostic efficacy as ESR and CRP.14 Baertl et al. found a more significant increase in IL-1β, IL-6, IL-10 and interferon-γ for high virulence Staphylococcus aureus than low virulence strains in mice models.15 Sabate-Bresco et al. found upregulation of IL-17A in all mice infected with Staphylococcus epidermidis.16 Hence, inflammatory cytokines may be useful for diagnosis of FRI, may correlate with the virulence of the organism, and elevations in specific inflammatory cytokines could potentially suggest the type of causative pathogen.

Developing a panel of inflammatory biomarkers for diagnosis of FRI can be considered. A prior study had evaluated plasma levels of 49 protein inflammatory biomarkers using enzyme-linked immunosorbent assays and mid-infrared spectral patterns to compare between 13 FRI patients and 13 matched controls,17 showed promising results. Future studies with a larger sample size can help identify key inflammatory biomarkers to be included in a diagnostic panel for FRI.

Hypocalcemia and thrombocytosis have also been observed to be associated with FRI. Liu et al. found that the incidence of asymptomatic hypocalcemia was significantly higher in FRI patients than patients with aseptic nonunion or controls (22.94 % vs 6.92 % vs 8.82 % respectively, p < 0.001).18 Platelets are acute phase reactants, whereby platelet count (PC) increases and mean platelet volume (MPV) decreases as a result of an infectious or inflammatory process. Hence, PC/MPV ratio has been found to be a promising tool for ruling out FRI with a specificity of 55.6 % and sensitivity of 100 %.19

3.2

3.2 Histopathology, microbiology and molecular diagnostics

In the context of PJI, studies have validated surgical sampling protocols and demonstrated that they improve culture yield.20,21 Strategies include cessation of antibiotics for at least two weeks prior to obtaining deep tissue culture, obtaining adequate tissue samples, and methods to avoid cross contamination such as the no touch technique when sampling. In the context of fractures whereby external forces have resulted in the primary injury, there may be superficial wounds that may or may not extend into the fracture site. This differs from PJI whereby there are often no superficial traumatic wounds. Hence, in the context of superficial traumatic injuries, one should avoid going through sites of superficial injury when obtaining cultures so as to avoid contamination and misdiagnosis of superficial infection as FRI.

Obtaining intramedullary cultures may also be considered. Onsea et al. evaluated the use of the Reamer-Irrigator-Apirator (RIA) system (Depuy Synthes; Johnson & Johnson Co, Inc,NJ), whereby RIA debris of patients with FRI demonstrated similar sensitivity to tissue cultures (71 % vs 67 %).22 In 4 out of 24 FRI patients, RIA cultures yielded additional relevant pathogens not found on standard tissue cultures. In the control group of aseptic nonunion patients, RIA cultures had no false positive.

Laboratory culture techniques can be optimized. Altering incubation conditions and processing techniques have been found to improve culture yield in PJI.23 The pathogens can be slow growing and low in numbers, and hence enriched cultures with prolonged incubation are necessary to improve yield.24 Vortexing with sterile glass beads may also have a role in facilitating biofilm disruption in FRI to improve detection.25,26 As pathogens in FRI and PJI have been demonstrated to have a similar pathogen distribution,27 applying the aforementioned concepts studied in PJI to FRI may improve culture yield as well. In summary, employing strict tissue sampling and laboratory processing protocols have been demonstrated to be effective in improving diagnosis in PJI, and thus should be implemented and evaluated in the context of FRI as well.

Previous studies have demonstrated that up to 15 % of PJI cases are culture negative,28,29 yet over 90 % of samples in culture negative patients demonstrate bacterial nucleic acid when molecular diagnostics are utilized.30 This is likely the case for FRI as well, whereby there can be a large proportion of false negative cultures. Real-time polymerase chain reaction (rt-PCR) panels can be performed to test for common pathogens in FRI. A search on Pubmed yielded eight studies on PCR techniques in FRI. Renz et al. compared sonication fluid PCR vs cultures, and found PCR to be comparable to cultures but with the added advantage of a shorter processing time and being a fully automated procedure.31 However, the performance of swab PCR is inferior to conventional tissue cultures.32

Metagenomics, which is the study of genetic material from a mixed community of organisms, may also aid with early detection of pathogens.33 It can be used to identify a wide range of pathogens inclusive of bacteria, viruses, fungi and parasites, and can also detect the presence of drug resistant genes in pathogens so as to guide pharmacological therapy. A 2021 expert consensus by the Laboratory Medicine Branch of the Chinese Medical Association had in fact recommended the use of metagenomic next-generation sequencing34 to identify pathogens in suspected infection sites whereby no causative organism has been identified through traditional laboratory techniques. However, molecular diagnostic techniques are costly, and hence should be utilized judiciously, perhaps only in patients whereby conventional culture techniques have yielded inconclusive results. Limitations of metagenomics include the fact that pathogens identified may be dead or dormant microorganisms that may not be of clinical significance, contamination by environmental pathogens can confound results, and that for intracellular pathogens, appropriate cell wall rupture methods must be utilized so that the intracellular organism can be identified. Hence, further large-scale trials are required to assess the clinical efficacy and cost effectiveness of molecular methods such as metagenomics.

Measuring wound alpha-defensin (AD) level has also showed promising results. AD is an antimicrobial peptide that is secreted by neutrophils in response to pathogenicity, so as to aid the host immune system with rapid killing of the pathogen. A search on Pubmed of utility of AD in FRI yields only one study. The study is a small prospective cohort study by Kumar et al.,35 wound AD levels were significantly elevated at a 2.6-fold increase in FRI patients as compared to controls. Future larger scale studies are required to further validated these results before wound AD can be used as a biomarker for diagnosis of FRI. Other wound biomarkers such as wound neutrophil esterase 2, bactericidal/permeability-increasing protein, neutrophil gelatinase-associated lipocalin and lactoferrin had previously shown promising results as biomarkers for PJI,36 and may be valuable investigating in the context of FRI as well.

MicroRNAs (miRNA) regulate proliferation and function of osteoblasts and osteoclasts, which are required for bone healing in fracture. In FRI, the inflammatory reaction as a result of infection impairs bone healing, and hence may be reflected by miRNA levels. It has been demonstrated that miRNA-331-3p is downregulated in rabbit models with infected nonunion fractures.37 Human studies are required to evaluate whether similar downregulation is observed in human subjects, and to explore whether miRNA-331-3p may be a potential therapeutic target to prevent nonunion caused by FRI.

An interesting study by Zhao et al. found dysbiosis of the gut microbiota to be associated with FRI.38 In the study, 50 participants with FRI, healed fracture with no FRI and healthy controls, underwent analysis of their gut microbiota present in fecal samples. Patients with FRI were found to have a higher abundance of bacteria of the genus Escherichia and Streptococcus, and a relative decrease in Roseburia as compared to subjects with healed fractures. Given the small study size and the observational case control nature of the study by Zhao et al., future prospective studies with a larger study population are required to further evaluate the causational relationship between FRI and gut dysbiosis, as opposed to the presence of gut dysbiosis being a risk factor for patients to develop FRI. Some hypotheses posit that stressors such as infection may cause intestinal ischemia-reperfusion, which affects the intestinal epithelial and mucosal layers, thereby driving gut dysbiosis. Other studies have also demonstrated how diseases such as ischaemic stroke, inflammatory bowel disease and ankylosing spondylitis can affect gut microbiota,39–41 and hence future studies to evaluate other confounding factors when using gut microbiota as a diagnostic tool for FRIs are needed.

3.3

3.3 Imaging

To achieve early detection of FRI, medical imaging techniques and modalities need to identify the presence of infection, the location of infection, and the extent of the infection. The diagnostic imaging principles utilized to identify PJI cannot be extrapolated to FRI as bone metabolism is increased in fracture healing, and hence may affect interpretation of infection on imaging.

Nuclear imaging is an up-and-coming field of imaging in modern day medicine. A Pubmed search yielded 15 studies on nuclear imaging in FRI. WBC scintigraphy can detect and localize metabolically active cells. Govaert et al.’s large retrospective single-center study found WBC scintigraphy to have a high diagnostic accuracy whereby the duration of the time interval between surgery and the scan, and concomitant use of antibiotics did not affect the diagnostic accuracy.42 By identifying the pattern of radiolabelled WBC accumulation over time, active infection can be discriminated from other causes of inflammation such as post-surgical changes and foreign body reactions, hence demonstrating a high specificity of 97 % and low sensitivity of only 79 %.43 PET/CT utilises fluorodeoxyglucose which is taken up by immune cells that use glucose as an energy source, thereby identifying highly metabolic areas. However, this does not allow for discrimination between infectious and inflammatory cells, and thus results in a poorer specificity of 91 % when evaluated in patients with osteomyelitis.44 It is likely that in FRI patients, fracture and recent surgical fixation would further confound the findings and lead to a poorer specificity, for which future studies can evaluate.

Future developments in nuclear imaging techniques should aim at identifying the causative pathogen of FRI. In addition, identifying specific resistance mechanisms of the pathogen, such as thickness and maturation of the biofilm, can provide information on challenges that may be faced in eradication of the pathogen, such that treatment methods can be titrated accordingly. Britton et al. utilized a radiolabelled antibiotic, ciprofloxacin, to identify specific bacteria, but only demonstrated a low specificity of 81.7 %.45 Future studies can evaluate the use of other radiolabelled antibiotics. Other infection specific imaging tracers can also be considered, such as compounds that would bind to bacterial cells (prokaryotic) but not to mammalian cells (eukaryotic).

Recently, fluorescent tracers have been gaining traction in tumour resection surgery.46 Fluorescent dye administered to patient pre-operatively results in illumination of the tumour of interest during cancer surgery, thereby detecting the site and extent of tumour to guide resection margins. When an external light source of a specific wavelength is used, the fluorescent tracer which is bound to the pathogen of interest would generate an optical signal on excitation, thereby illuminating the target tissue.47 A Pubmed search revealed four studies on use of fluorescence in FRI. Lopez-Alvarez et al. evaluated the use of a near-infrared fluorescent tracer composed of antitbiotic vancomycin and fluorophore IRDye800CW applied to extracted orthopaedic implants, which allowed prompt diagnosis of FRI to within <30min, and is a potential means for on table diagnosis of FRI.48 Future research can evaluate if such methods may similarly be applicable to FRI through developing targeted fluorescent tracers with a targeting moiety that has binding affinity for specific pathogen-associated molecular targets or biomarkers. Fluorescence image-guided surgery can also enable the orthopaedic surgeon to identify the presence of infection intra-operatively by looking for tissues that illuminate, and carry out sufficient surgical debridement and decontamination such that the visible pathogen load viewed via in vivo optical imaging is reduced to a minimum prior to wound closure, so as to achieve optimal source control. Rupp et al. evaluated the use of VELscope, an intraoperative tool to differentiate between viable and necrotic bone using fluorescent technology, and found the technology to have good correlation with pathohistological findings of bone necrosis, thereby aiding adequate intra-operative bone resection in patients with chronic FRI.49

4

4 Conclusion

FRI is a rapidly growing field in orthopaedic trauma surgery. Previous attempts at studying this topic had been hampered by the lack of a clear definition of FRI, hence resulting in heterogenous study populations that impaired the ability to draw conclusions on the efficacy of FRI diagnostics and formulate protocols for the early detection of FRI. Promising diagnostic methods for early detection of FRI include molecular techniques and nuclear imaging. With the current consensus definition for FRI, future large prospective trials are needed to compare the various diagnostic modalities for FRI not included in the current FRI consensus definition, with the aim of identifying the better diagnostic techniques. In addition, every trauma patient is unique, and there may be patient and disease factors, such as comorbidities of a patient (eg. presence of osteoporosis, diabetes mellitus), and the site and severity of the trauma, that may result in varying efficacies of each diagnostic modality. Hence, as understanding of FRI continues to improve and progress, future research may consider subgroup analyses of different patient types to identify diagnostic modalities that will allow for early detection of FRI in specific patient subtypes.

Funding/sponsorship

None.

Informed consent (Patient/Guardian), mandatory only for case reports/clinical images

Not Applicable.

Institutional ethical committee approval (for all human studies)

Not Applicable.

Institutional ethical committee approval (for all human studies)

Not Applicable.

Funding/sponsorship

None.

CRediT authorship contribution statement

Hui Wen Tay: Investigation, Writing – original draft, Writing – review & editing. Kae Sian Tay: Conceptualization, Supervision, Writing – review & editing.

References

  1. , , , , . The epidemiology of fracture-related infections in Germany. Sci Rep. 2021;11(1)
    [Google Scholar]
  2. , , , , , . The multifactorial aetiology of fracture nonunion and the importance of searching for latent infection. Bone Joint Res. 2016;5(10):512-519.
    [Google Scholar]
  3. , , , et al . Fracture-related infection: a consensus on definition from an international expert group. Injury. 2018;49(3):505-510.
    [Google Scholar]
  4. , , , , , , . Limited diagnostic value of serum inflammatory biomarkers in the diagnosis of fracture-related infections. Bone Joint Lett J. 2020;102-B(7):904-911.
    [Google Scholar]
  5. , , . Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol. 2012;65(2):158-168.
    [Google Scholar]
  6. , , , et al . Diagnostic accuracy of serum inflammatory markers in late fracture-related infection: a systematic review and meta-analysis. Bone Joint Lett J. 2018;100(12):1542-1550.
    [Google Scholar]
  7. , , , et al . Accuracy of tissue and sonication fluid sampling for the diagnosis of fracture-related infection: a systematic review and critical appraisal. J Bone Jt Infect. 2018;3(4):173-181.
    [Google Scholar]
  8. , , , et al . Sonication versus tissue sampling for diagnosis of prosthetic joint and other orthopedic device-related infections. J Clin Microbiol. 2018;56(12):10-1128.
    [Google Scholar]
  9. , , , , , , . The value of quantitative histology in the diagnosis of fracture-related infection. Bone Joint Lett J. 2018;100(7):966-972.
    [Google Scholar]
  10. , , , , . The value of conventional radiographs for diagnosing internal fixation-associated infection. BMC Muscoskel Disord. 2021;22(1):411.
    [Google Scholar]
  11. , , , et al . Pathogenesis and management of fracture-related infection. Clin Microbiol Infection. 2020;26(5):572-578.
    [Google Scholar]
  12. , , , et al . Consensus document for the diagnosis of peripheral bone infection in adults: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement) Eur J Nucl Med Mol Imag. 2019;46:957-970.
    [Google Scholar]
  13. , , , , , , . Accuracy of diagnostic imaging modalities for peripheral post-traumatic osteomyelitis–a systematic review of the recent literature. Eur J Nucl Med Mol Imag. 2017;44:1393-1407.
    [Google Scholar]
  14. , , , , , . Interleukin-6 versus common inflammatory biomarkers for diagnosing fracture-related infection: utility and potential influencing factors. J Immunol Res. 2021;2021
    [Google Scholar]
  15. , , , et al . Staphylococcus aureus from an acute fracture-related infection displays important bacteriological and histopathologic differences from a chronic equivalent in a murine bone infection model. Clin Orthop Relat Res. 2023;481(10)
    [Google Scholar]
  16. , , , et al . Fracture biomechanics influence local and systemic immune responses in a murine fracture-related infection model. Biol Open. 2021;10(9)
    [Google Scholar]
  17. , , , et al . Utility of plasma protein biomarkers and mid-infrared spectroscopy for diagnosing fracture-related infections: a pilot study. J Orthop Trauma. 2022;36(10):e380-e387.
    [Google Scholar]
  18. , , , , , , . Serum calcium level combined with platelet count may Be useful indicators for assisted diagnosis of extremity posttraumatic osteomyelitis: a comparative analysis. Dis Markers 2021:2021.
    [Google Scholar]
  19. , , , , , , . An adjunct indicator for the diagnosis of fracture-related infections: platelet count to mean platelet volume ratio. J Bone Jt Infect. 2020;5(2):54-59.
    [Google Scholar]
  20. , , , et al . Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J Clin Microbiol. 1998;36(10):2932-2939.
    [Google Scholar]
  21. , , , et al . How many samples and how many culture media to diagnose a prosthetic joint infection: a clinical and microbiological prospective multicenter study. J Clin Microbiol. 2016;54(2):385-391.
    [Google Scholar]
  22. , , , et al . Intramedullary tissue cultures from the Reamer-Irrigator-Aspirator system for diagnosing fracture-related infection. J Orthop Res. 2021;39(2):281-290.
    [Google Scholar]
  23. , , , et al . Improved diagnosis of prosthetic joint infection by culturing periprosthetic tissue specimens in blood culture bottles. mBio. 2016;7(1):10-1128.
    [Google Scholar]
  24. , , , , , , . Microbiological diagnosis of prosthetic joint infections: a prospective evaluation of four bacterial culture media in the routine laboratory. Clin Microbiol Infection. 2011;17(10):1528-1530.
    [Google Scholar]
  25. , , , et al . Diagnosis of prosthetic joint infection by beadmill processing of a periprosthetic specimen. Clin Microbiol Infection. 2011;17(3):447-450.
    [Google Scholar]
  26. , , , et al . Prospective analysis of a sterile, semi–automated tissue biopsy homogenization method in the diagnosis of prosthetic joint infections. In Vivo. 2017;31(5):937-942.
    [Google Scholar]
  27. , , , , , , . Is there a difference in microbiological epidemiology and effective empiric antimicrobial therapy comparing fracture-related infection and periprosthetic joint infection? A retrospective comparative study. Antibiotics. 2021;10(8):921.
    [Google Scholar]
  28. , , , et al . Culture-negative prosthetic joint infection. Clin Infect Dis. 2007;45(9):1113-1119.
    [Google Scholar]
  29. , , , , , , . Culture-negative periprosthetic joint infections. EFORT Open Rev. 2019;4(10):585-594.
    [Google Scholar]
  30. , , , et al . Comparison of cultures and 16S rRNA sequencing for identification of bacteria in two-stage revision arthroplasties: preliminary report. BMC Muscoskel Disord. 2016;17:1-10.
    [Google Scholar]
  31. , , , , , . Value of PCR in sonication fluid for the diagnosis of orthopedic hardware-associated infections: has the molecular era arrived? Injury. 2018;49(4):806-811.
    [Google Scholar]
  32. , , , et al . Diagnostic performance of swab PCR as an alternative to tissue culture methods for diagnosing infections associated with fracture fixation devices. Injury. 2016;47(7):1421-1426.
    [Google Scholar]
  33. , , , et al . Advances in metagenomics and its application in environmental microorganisms. Front Microbiol. 2021;12
    [Google Scholar]
  34. , . Next-generation DNA sequencing methods. Annu Rev Genom Hum Genet. 2008;9:387-402.
    [Google Scholar]
  35. , , , et al . Wound alpha defensin levels are significantly higher in patients with fracture related infection: a pilot, prospective cohort study. Injury. 2023;54(2):416-421.
    [Google Scholar]
  36. , , , , , , . The role of alpha defensin in prosthetic joint infection (PJI) diagnosis: a literature review. EFORT Open Rev. 2019;4(1):10-13.
    [Google Scholar]
  37. , , , et al . Transcriptome sequencing profiling identifies miRNA-331-3p as an osteoblast-specific miRNA in infected bone nonunion. Bone. 2021;143
    [Google Scholar]
  38. , , , et al . Altered gut microbiota as an auxiliary diagnostic indicator for patients with fracture-related infection. Front Microbiol. 2022;13
    [Google Scholar]
  39. , , , et al . Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn. Gut. 2021;70(8):1486-1494.
    [Google Scholar]
  40. , , , et al . Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann Rheum Dis. 2017;76(6):1123-1132.
    [Google Scholar]
  41. , , , , , . The gut microbiome in inflammatory bowel disease—avenues for microbial management. Aliment Pharmacol Ther. 2018;47(1):26-42.
    [Google Scholar]
  42. , , , et al . High diagnostic accuracy of white blood cell scintigraphy for fracture related infections: results of a large retrospective single-center study. Injury. 2018;49(6):1085-1090.
    [Google Scholar]
  43. , , , , , , . A large retrospective single-centre study to define the best image acquisition protocols and interpretation criteria for white blood cell scintigraphy with 99m Tc-HMPAO-labelled leucocytes in musculoskeletal infections. Eur J Nucl Med Mol Imag. 2013;40:1760-1769.
    [Google Scholar]
  44. , , , , , , . The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. JBJS. 2005;87(11):2464-2471.
    [Google Scholar]
  45. , , , et al . Imaging bacterial infection with 99mTc-ciprofloxacin (Infecton) J Clin Pathol. 2002;55(11):817.
    [Google Scholar]
  46. , , . Emerging fluorescent molecular tracers to guide intra-operative surgical decision-making. Front Pharmacol. 2019;10
    [Google Scholar]
  47. , , , , , . Molecular imaging of infectious and inflammatory diseases: a terra incognita. J Nucl Med. 2015;56(5):659-661.
    [Google Scholar]
  48. , , , et al . Bacteria-targeted fluorescence imaging of extracted osteosynthesis devices for rapid visualization of fracture-related infections. Eur J Nucl Med Mol Imag. 2022;49(7):2276-2289.
    [Google Scholar]
  49. , , , et al . Can necrotic bone be objectively identified in chronic fracture related infections? — First clinical experience with an intraoperative fluorescence imaging technique. Injury. 2020;51(11):2541-2545.
    [Google Scholar]
Show Sections